--2025/Q1-- / 1.268M--
--2024/Q4-- / 1.701M--
--2024/Q33.336M / 1.520M--
--2024/Q22.658M / 1.289M--
--2024/Q11.717M / 1.213M--
Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
CUE Cue Biopharma
- 1.490
- +0.070+4.93%
Close Feb 14 16:00 ET
- 1.490
- 0.0000.00%
Post 20:01 ET
94.39MMarket Cap-1.64P/E (TTM)
1.500High1.397Low183.12KVolume1.450Open1.420Pre Close266.95KTurnover0.29%Turnover RatioLossP/E (Static)63.35MShares2.37052wk High3.73P/B93.87MFloat Cap0.45052wk Low--Dividend TTM63.00MShs Float31.690Historical High--Div YieldTTM7.23%Amplitude0.450Historical Low1.457Avg Price1Lot Size
Cue Biopharma Key Stats
Cue Biopharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Cue Biopharma Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.